<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">BMC Infect Dis</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40001073</article-id><article-id pub-id-type="pmc">PMC11863440</article-id>
<article-id pub-id-type="publisher-id">10661</article-id><article-id pub-id-type="doi">10.1186/s12879-025-10661-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Prognostic nutritional index as an early predictor of mortality in patients with severe fever with thrombocytopenia syndrome: multicenter retrospective study in South Korea</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0008-0894-2349</contrib-id><name><surname>Woo</surname><given-names>Hyun Ji</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kwon</surname><given-names>Tae-Kyu</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8947-5069</contrib-id><name><surname>Heo</surname><given-names>Sang Taek</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5488-7925</contrib-id><name><surname>Yoo</surname><given-names>Jeong Rae</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3771-6101</contrib-id><name><surname>Kim</surname><given-names>Misun</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6275-8587</contrib-id><name><surname>Oh</surname><given-names>Jaeseong</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9929-2271</contrib-id><name><surname>Bae</surname><given-names>In-Gyu</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0206-7108</contrib-id><name><surname>Bae</surname><given-names>Sohyun</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2166-7579</contrib-id><name><surname>Yoon</surname><given-names>Young-Ran</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0062-342X</contrib-id><name><surname>Hyun</surname><given-names>Miri</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9125-7156</contrib-id><name><surname>Kim</surname><given-names>Hyun ah</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1577-678X</contrib-id><name><surname>Jung</surname><given-names>Sook In</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4666-0672</contrib-id><name><surname>Kwon</surname><given-names>Ki Tae</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3618-174X</contrib-id><name><surname>Hwang</surname><given-names>Soyoon</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8463-6297</contrib-id><name><surname>Kim</surname><given-names>Uh Jin</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9841-1139</contrib-id><name><surname>Kang</surname><given-names>Gaeun</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3824-0184</contrib-id><name><surname>Kim</surname><given-names>Young Jun</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2114-1374</contrib-id><name><surname>Hwang</surname><given-names>Jeong-Hwan</given-names></name><address><email>smilehwang77@hanmail.net</email></address><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7269-9533</contrib-id><name><surname>Kim</surname><given-names>Min-Gul</given-names></name><address><email>mgkim@jbnu.ac.kr</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05q92br09</institution-id><institution-id institution-id-type="GRID">grid.411545.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4320</institution-id><institution>Department of Healthcare Engineering, Graduate School, </institution><institution>Jeonbuk National University, </institution></institution-wrap>Jeonju, Republic of Korea </aff><aff id="Aff2"><label>2</label>Nanum Space Co., Ltd, Jeonju, Jeonbuk Republic of Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05q92br09</institution-id><institution-id institution-id-type="GRID">grid.411545.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4320</institution-id><institution>Division of Biomedical Engineering, College of Engineering, </institution><institution>Jeonbuk National University, </institution></institution-wrap>Jeonju, Republic of Korea </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05hnb4n85</institution-id><institution-id institution-id-type="GRID">grid.411277.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0725 5207</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Jeju National University Hospital, Jeju National University School of Medicine, </institution></institution-wrap>Jeju, Republic of Korea </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05hnb4n85</institution-id><institution-id institution-id-type="GRID">grid.411277.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0725 5207</institution-id><institution>Department of Pharmacology, </institution><institution>Jeju National University School of Medicine, Jeju National University Hospital, </institution></institution-wrap>Jeju, Republic of Korea </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00saywf64</institution-id><institution-id institution-id-type="GRID">grid.256681.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0661 1492</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, </institution></institution-wrap>Jinju, Republic of Korea </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04qn0xg47</institution-id><institution-id institution-id-type="GRID">grid.411235.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 192X</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Kyungpook National University Hospital, Kyungpook National University School of Medicine, </institution></institution-wrap>Daegu, Republic of Korea </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040c17130</institution-id><institution-id institution-id-type="GRID">grid.258803.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0661 1556</institution-id><institution>Department of Clinical Pharmacology, </institution><institution>Kyungpook National University Hospital, Kyungpook National University School of Medicine, </institution></institution-wrap>Daegu, Republic of Korea </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00tjv0s33</institution-id><institution-id institution-id-type="GRID">grid.412091.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0669 3109</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Keimyung University Dongsan Hospital, Keimyung University School of Medicine, </institution></institution-wrap>Daegu, Republic of Korea </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f200z37</institution-id><institution-id institution-id-type="GRID">grid.411597.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 2471</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Chonnam National University Hospital, Chonnam National University Medical School, </institution></institution-wrap>Gwangju, Republic of Korea </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040c17130</institution-id><institution-id institution-id-type="GRID">grid.258803.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0661 1556</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Kyungpook National University Chilgok Hospital, Kyungpook National University School of Medicine, </institution></institution-wrap>Daegu, Republic of Korea </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/054gh2b75</institution-id><institution-id institution-id-type="GRID">grid.411602.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 9534</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Chonnam National University Hwasun Hospital, Chonnam National University School of Medicine, </institution></institution-wrap>Gwangju, Republic of Korea </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f200z37</institution-id><institution-id institution-id-type="GRID">grid.411597.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 2471</institution-id><institution>Division of Clinical Pharmacology, </institution><institution>Chonnam National University Hospital, </institution></institution-wrap>Gwangju, Republic of Korea </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/006776986</institution-id><institution-id institution-id-type="GRID">grid.410899.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0533 4755</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Wonkwang University Hospital, </institution></institution-wrap>Iksan, Republic of Korea </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05q92br09</institution-id><institution-id institution-id-type="GRID">grid.411545.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4320</institution-id><institution>Division of Infectious Diseases, Department of Internal Medicine, </institution><institution>Jeonbuk National University Hospital, Jeonbuk National University Medical School, </institution></institution-wrap>Jeonju, Republic of Korea </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05q92br09</institution-id><institution-id institution-id-type="GRID">grid.411545.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4320</institution-id><institution>Department of Pharmacology, </institution><institution>Jeonbuk National University Medical School, </institution></institution-wrap>Jeonju, Republic of Korea </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>274</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>17</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background and aim</title><p id="Par1">Severe fever with thrombocytopenia syndrome (SFTS) is a fatal tick-borne infectious disease lacking effective treatments or vaccines. Early identification of prognostic factors is essential for optimizing clinical management. This study investigated the predictors for mortality in SFTS patients.</p></sec><sec><title>Methods</title><p id="Par2">We conducted a retrospective multicenter cohort study of 413 SFTS patients hospitalized in South Korea from 2013 to 2024. Clinical and laboratory data were comprehensively analyzed to evaluate associations between in-hospital mortality and various inflammatory, immune, and nutritional biomarkers. Cox regression and time-dependent receiver operating characteristic (ROC) analyses were performed to identify risk factors.</p></sec><sec><title>Results</title><p id="Par3">413 patients diagnosed with SFTS were included and In-hospital mortality was 17% (70/413). Multivariate Cox regression identified older age (HR: 1.042; 95% CI: 1.014&#x02013;1.071), elevated PT(INR) (HR: 109.57; 95% CI: 19.79&#x02013;606.57), and lower prognostic nutritional index (PNI) (HR: 0.937; 95% CI: 0.886&#x02013;0.990) as early predictors of mortality. Time-dependent ROC analysis demonstrated predictive accuracy, with AUCs of 0.512 for age, 0.857 for PT(INR), and 0.694 for PNI at 30 days. Kaplan-Meier analysis revealed significant survival differences for patients stratified by PNI (&#x0003c;&#x02009;40.75), PT(INR) (&#x02265;&#x02009;0.97), and age (&#x02265;&#x02009;59 years).</p></sec><sec><title>Conclusions</title><p id="Par4">PNI, PT(INR), and age were identified as key early predictors of mortality in SFTS. PNI, as a novel biomarker, was found to be a useful index for risk level and treatment strategies in SFTS patients.</p></sec><sec><title>Clinical trial number</title><p id="Par5">Not applicable.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12879-025-10661-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Severe fever with thrombocytopenia syndrome</kwd><kwd>Prognostic nutritional index</kwd><kwd>Early predictor</kwd><kwd>Biomarker</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003710</institution-id><institution>Korea Health Industry Development Institute</institution></institution-wrap></funding-source><award-id>HI22C0797</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease first identified in China in 2009 and subsequently reported in other Asian countries, including South Korea, Japan, and Vietnam [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. In 2014, the pathogen was officially classified as the SFTS virus by the International Committee on Taxonomy of Viruses, and in 2019, it was renamed <italic>Dabie bandavirus</italic> and reclassified into the genus <italic>Bandavirus</italic>, family <italic>Phenuiviridae</italic>, and order <italic>Bunyavirales</italic> [<xref ref-type="bibr" rid="CR5">5</xref>]. SFTS virus is primarily transmitted through tick bites, although human-to-human transmission via close contact has been reported [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. The Heartland virus, which shares genetic similarities with SFTS, has been identified in the United States, indicating the potential for global dissemination of SFTS. In 2017, the World Health Organization (WHO) classified SFTS as one of the top 10 priority infectious diseases requiring urgent research, alongside Ebola [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par7">The common symptoms of SFTS include high fever, fatigue, headache, myalgia, abdominal pain, vomiting, diarrhea, and cough, which are nonspecific. Frequent clinical signs include thrombocytopenia, leukopenia, lymphadenopathy, and gastrointestinal bleeding, with an estimated case fatality rate ranging from 16.2 to 30% [<xref ref-type="bibr" rid="CR10">10</xref>]. The pathophysiology of SFTS is still poorly understood, and there are currently no effective vaccines or antiviral therapies for prevention or treatment. Most studies have focused on the clinical features and laboratory findings of SFTS, which are insufficient to predict disease severity or guide therapeutic strategies accurately.</p><p id="Par8">SFTS is closely associated with immune dysregulation, which plays a critical role in its pathogenesis, determining the progression and severity of the disease [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. Excessive activation of circulating leukocytes, particularly in response to viremia, reflects systemic inflammation resulting from a failure of cell-intrinsic immunity to control the intracellular virus in leukocytes or other cells. Specifically, SFTS virus triggers an exaggerated inflammatory response &#x02014; characterized by the excessive production of proinflammatory cytokines, including IL-1&#x003b2;, IL-6, IL-8, TNF-&#x003b1;, IFN-&#x003b3; and IL-10 &#x02014; which correlates with viral load and reflects the severity of the inflammatory state [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. This cytokine storm is related to severe complications, such as multiple organ dysfunction syndrome, shock, and disseminated intravascular coagulation, ultimately causing increased mortality [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. As a result, patients with SFTS often have severe systemic inflammation, as well as immune dysregulation, hepatic dysfunction, and coagulation abnormalities. Several studies have reported that systemic inflammatory biomarkers &#x02014; such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), C-reactive protein-to-lymphocyte ratio (CLR), C-reactive protein-to-albumin ratio (CAR), BUN-to-Albumin Ratio (BAR), and AST-to-ALT Ratio (AAR) &#x02014; are predictors for the prognosis of patients with SFTS [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. Other inflammatory biomarkers whose association to the prognosis of patients with SFTS has not yet been established include systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI). These biomarkers may help identify high-risk patients early, allowing for appropriate treatment [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par9">Nutritional status is also important in predicting the prognosis of SFTS mortality because malnutrition can exacerbate systemic inflammation and impair immune competence. Platelet-to-Albumin Ratio (PAR) and prognostic nutritional index (PNI) are representative biomarkers of nutritional and immune status [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. These indices indicate the interaction between systemic inflammation, immune competence, and nutritional reserves, making them a comprehensive biomarker of disease progression. For example, PNI, calculated from serum albumin levels and total lymphocyte counts, is independently associated with long-term survival in patients with acute heart failure [<xref ref-type="bibr" rid="CR32">32</xref>]. Lower PNI values indicate hypoalbuminemia and lymphopenia, conditions often consistent with systemic inflammation and impaired immune function in SFTS. Thus, nutritional status indices may be useful in predicting the prognosis of SFTS. While other markers (e.g., NLR, CLR, CRP, SII, or SIRI) mainly focus on inflammatory states or platelet-related parameters, the PNI was initially designed to evaluate both nutritional and immunological status. This dual perspective may be especially relevant in SFTS, where hepatic dysfunction and immune dysregulation frequently occur together [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Despite the increasing importance of PNI in various critical illnesses, its role in SFTS prognosis remains insufficiently studied [<xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR38">38</xref>]. By comparing PNI to other established or emerging biomarkers, it is important to clarify whether PNI offers prognostic value and can serve as a novel, comprehensive index for early risk classification in SFTS.</p><p id="Par10">In this study, we developed and evaluated a predictive model for in-hospital mortality of SFTS patients using various parameters representing the initial clinical status, including demographic, routine laboratory data, and a comprehensive set of inflammatory, immune, and nutritional indices. Our objective was to determine whether these variables can effectively predict mortality and provide a basis for clinical decision-making, thereby assisting early risk classification and supporting timely therapeutic intervention.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and patient selection</title><p id="Par11">This retrospective, multicenter cohort study was conducted nationwide in South Korea, using nine tertiary referral hospitals with infectious diseases specialists. We included patients with a confirmed diagnosis of SFTS who were hospitalized and treated between May 2013 and October 2024. SFTS virus infection was confirmed by detecting viral RNA in patient serum during the acute phase of illness using real-time polymerase chain reaction (RT-PCR) or Conventional reverse transcription PCR. Conventional reverse transcription PCR was used initially but was replaced by RT-PCR in early 2016; thus, most patients in this study were diagnosed by RT-PCR. We excluded patients who were not admitted to the ward, meaning those evaluated only in the outpatient clinic or those who left the hospital against medical advice, resulting in no available in-hospital follow-up data. We also excluded patients with no laboratory tests performed within 1&#x000a0;day of hospital admission, since we lacked baseline laboratory results on the admission day or the following day. This approach ensured consistent time-point measurements for subsequent analyses.</p><p id="Par12">The study protocol was approved by each hospital&#x02019;s Institutional Review Board. The list of IRBs and IRB approval numbers is provided in Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>. The requirement for informed consent was waived due to the study&#x02019;s retrospective nature and the use of de-identified patient data.</p></sec><sec id="Sec4"><title>Data collection and variable definition</title><p id="Par13">Demographic, clinical, and laboratory data were collected from the electronic medical records of each hospital. Laboratory parameters were obtained explicitly from tests conducted on the day of hospital admission or the day after admission to capture the most clinically relevant values at the acute phase of SFTS. If data from these time points were unavailable, they were recorded as missing. The laboratory data included key hematological and biochemical measures such as white blood cell count, platelet count, aspartate aminotransferase (AST), and albumin. The primary outcome was in-hospital mortality, defined as death occurring during the hospitalization.</p><p id="Par14">The following indices were calculated based on the available laboratory data:</p><p id="Par15">
<list list-type="bullet"><list-item><p id="Par16">Neutrophil-to-Lymphocyte Ratio (NLR)&#x02009;=&#x02009;neutrophil/lymphocyte counts.</p></list-item><list-item><p id="Par17">Platelet-to-Lymphocyte ratio (PLR)&#x02009;=&#x02009;platelet/lymphocyte counts.</p></list-item><list-item><p id="Par18">Monocyte-to-Lymphocyte ratio (MLR)&#x02009;=&#x02009;monocyte/lymphocyte counts.</p></list-item><list-item><p id="Par19">Systemic inflammation index (SII)&#x02009;=&#x02009;platelet counts&#x000d7;neutrophil counts/lymphocyte counts.</p></list-item><list-item><p id="Par20">Systemic inflammation response index (SIRI)&#x02009;=&#x02009;neutrophil counts&#x000d7;monocyte counts /lymphocyte counts.</p></list-item><list-item><p id="Par21">Aggregate systemic inflammation index (AISI)&#x02009;=&#x02009;neutrophil counts&#x000d7;monocyte counts&#x000d7;platelet counts/lymphocyte counts.</p></list-item><list-item><p id="Par22">C-reactive protein-to-Lymphocyte Ratio (CLR)&#x02009;=&#x02009;CRP/lymphocyte counts.</p></list-item><list-item><p id="Par23">C-reactive protein-to-albumin ratio (CAR)&#x02009;=&#x02009;CRP/albumin.</p></list-item><list-item><p id="Par24">BUN-to-ALB ratio (BAR)&#x02009;=&#x02009;BUN/albumin.</p></list-item><list-item><p id="Par25">Platelet-to-albumin ratio (PAR)&#x02009;=&#x02009;platelet counts/albumin.</p></list-item><list-item><p id="Par26">Prognostic nutritional index (PNI)&#x02009;=&#x02009;albumin (g/dl)&#x000d7;10&#x02009;+&#x02009;5&#x000d7;lymphocyte count (&#x000d7;10&#x000b3;/&#x000b5;L).</p></list-item><list-item><p id="Par27">AST/ALT ratio (AAR; De Ritis ratio)&#x02009;=&#x02009;AST/ALT.</p></list-item></list>
</p><p id="Par28">These indices were selected based on emerging evidence that they may reflect the inflammatory state, as well as nutritional status and immune competence of various infectious and critical illnesses.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par29">All statistical analyses were performed using R software version 4.4.2 (R Foundation for Statistical Computing, Vienna, Austria). Continuous variables were presented as mean&#x02009;&#x000b1;&#x02009;standard deviation or median (interquartile range), according to data distribution. Categorical variables were expressed as frequencies and percentages. Differences between survivors and non-survivors were evaluated using the Student&#x02019;s t-test or Mann-Whitney U test for continuous variables and the Chi-square test for categorical variables.</p><p id="Par30">Time-to-event analysis was performed using the Cox proportional hazards regression model with <italic>survival</italic> package. Time-to-event was defined from symptom onset to death (event&#x02009;=&#x02009;1) or censored at discharge (event&#x02009;=&#x02009;0). Univariate Cox regression analyses were performed to identify candidate predictors of mortality. Then, variables with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 were considered in the multivariate Cox model. Least absolute shrinkage and selection operator (LASSO) Cox regression analysis was performed to screen potential prognostic factors using the <italic>glmnet</italic> package. Ten-fold cross-validation was used to select the optimal lambda, with the lambda value (&#x003bb;_min) that minimizes the cross-validated error subsequently used to fit the LASSO Cox model and extract coefficients corresponding to non-zero predictors. The variables selected by the LASSO Cox regression analysis were then subjected to multivariate Cox regression analysis using a forward selection method to identify independent risk factors for fatal outcomes in SFTS patients. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were reported to identify independent predictors of mortality. Additionally, stratified Cox regression analyses were conducted to assess the prognostic impact of selected predictors across different subgroups defined by age, gender, and hospital location. For the analysis of the predictive model, the pairwise deletion method was used to handle missing data [<xref ref-type="bibr" rid="CR39">39</xref>]. This method allows the inclusion of available data for each variable individually rather than excluding an entire case when one variable is missing.</p><p id="Par31">To evaluate the predictive performance of the selected variables at specific time points while properly accounting for patients who were censored, we performed a time-dependent receiver operating characteristic (ROC) analysis using the <italic>timeROC</italic> package. Time-dependent ROC curves and corresponding area under the curve (AUC) values were calculated at t&#x02009;=&#x02009;7 and 30 days for each predictor variable. The AUC was calculated to measure predictive accuracy, and optimal cut-off values were determined using the Youden index to maximize sensitivity and specificity. The key predictor variables were dichotomized based on their respective cut-off value. Kaplan-Meier survival curves were generated for each dichotomized variable, and survival differences were compared using the log-rank test.</p><p id="Par32">To verify the proportional hazards assumption for the Cox regression and Kaplan-Meier analyses, both statistical tests and graphical methods were applied. Specifically, the Schoenfeld residuals test was used to assess the proportional hazards assumption statistically, and log-log survival plots and Schoenfeld residual plots were generated to inspect the assumption visually. No violations of the proportional hazards assumption were detected for the main predictors.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Patients characteristics</title><p id="Par33">A total of 413 patients diagnosed with SFTS were included in this study (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Baseline demographic and clinical characteristics are presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The non-survivors were older, had a higher prevalence of diabetes mellitus, and had shorter durations from onset of illness to discharge or death (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p id="Par34">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Study Flow Chart of Patient Selection. &#x02018;No admission to ward&#x02019; indicates patients were seen only in the outpatient clinic or left the hospital against medical advice, providing no in-hospital follow-up data. &#x02018;No laboratory tests within 1&#x000a0;day&#x02019; indicates who had no baseline lab results obtained on the day of admission or the following day</p></caption><graphic xlink:href="12879_2025_10661_Fig1_HTML" id="d33e658"/></fig>
</p><p id="Par35">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics of patients with SFTS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristics</th><th align="left">Overall (<italic>n</italic>&#x02009;=&#x02009;413)</th><th align="left">Survivors (<italic>n</italic>&#x02009;=&#x02009;343)</th><th align="left">Non-survivor (<italic>n</italic>&#x02009;=&#x02009;70)</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="5">
<italic>Demographics</italic>
</td></tr><tr><td align="left">&#x02003;Age (year)</td><td align="left">67.12 (13.28)</td><td align="left">65.84 (13.63)</td><td align="left">73.40 (9.20)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" colspan="5">&#x02003;Gender, n (%)</td></tr><tr><td align="left">&#x02003;&#x02003;Male</td><td align="left">194 (47.0)</td><td align="left">163 (47.5)</td><td align="left">31 (44.3)</td><td align="left" rowspan="2">0.717</td></tr><tr><td align="left">&#x02003;&#x02003;Female</td><td align="left">219 (53.0)</td><td align="left">180 (52.5)</td><td align="left">39 (55.7)</td></tr><tr><td align="left">&#x02003;Height (cm)</td><td align="left">161.79 (9.73)</td><td align="left">161.71 (9.99)</td><td align="left">162.18 (8.38)</td><td align="left">0.735</td></tr><tr><td align="left">&#x02003;Weight (kg)</td><td align="left">61.34 (13.35)</td><td align="left">61.22 (13.33)</td><td align="left">61.91 (13.54)</td><td align="left">0.705</td></tr><tr><td align="left" colspan="5">
<italic>Signs &#x00026; Symptoms</italic>
</td></tr><tr><td align="left">&#x02003;Body temperature</td><td align="left">37.48 (0.88)</td><td align="left">37.48 (0.88)</td><td align="left">37.51 (0.87)</td><td align="left">0.781</td></tr><tr><td align="left">&#x02003;Systolic blood pressure</td><td align="left">119.70 (19.60)</td><td align="left">119.97 (19.70)</td><td align="left">118.39 (19.20)</td><td align="left">0.538</td></tr><tr><td align="left">&#x02003;Diastolic blood pressure</td><td align="left">71.63 (13.69)</td><td align="left">71.69 (13.66)</td><td align="left">71.34 (13.95)</td><td align="left">0.846</td></tr><tr><td align="left">&#x02003;Heart rate</td><td align="left">81.20 (15.59)</td><td align="left">81.00 (15.24)</td><td align="left">82.17 (17.28)</td><td align="left">0.568</td></tr><tr><td align="left">&#x02003;Respiratory rate</td><td align="left">19.76 (2.11)</td><td align="left">19.69 (2.02)</td><td align="left">20.10 (2.47)</td><td align="left">0.136</td></tr><tr><td align="left">&#x02003;Glasgow coma scale</td><td align="left">14.64 (1.32)</td><td align="left">14.82 (0.75)</td><td align="left">13.76 (2.58)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;APACHE II Score</td><td align="left">25.51 (4.11)</td><td align="left">25.40 (4.03)</td><td align="left">26.07 (4.44)</td><td align="left">0.211</td></tr><tr><td align="left">&#x02003;O<sub>2</sub> supply, n (%)</td><td align="left">70 (16.9)</td><td align="left">38 (11.1)</td><td align="left">32 (45.7)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Fever, n (%)</td><td align="left">298 (72.2)</td><td align="left">248 (72.3)</td><td align="left">50 (71.4)</td><td align="left">0.998</td></tr><tr><td align="left">&#x02003;Headache, n (%)</td><td align="left">70 (16.9)</td><td align="left">57 (16.6)</td><td align="left">13 (18.6)</td><td align="left">0.824</td></tr><tr><td align="left">&#x02003;Dyspnea, n (%)</td><td align="left">14 (3.4)</td><td align="left">9 (2.6)</td><td align="left">5 (7.1)</td><td align="left">0.123</td></tr><tr><td align="left" colspan="5">
<italic>Comorbidities</italic>
</td></tr><tr><td align="left">&#x02003;Diabetes, n (%)</td><td align="left">70 (16.9)</td><td align="left">51 (14.9)</td><td align="left">19 (27.1)</td><td align="left">0.020</td></tr><tr><td align="left">&#x02003;Hypertension, n (%)</td><td align="left">154 (37.3)</td><td align="left">121 (35.3)</td><td align="left">33 (47.1)</td><td align="left">0.083</td></tr><tr><td align="left">&#x02003;Chronic lung disease, n (%)</td><td align="left">47 (11.4)</td><td align="left">35 (10.2)</td><td align="left">12 (17.1)</td><td align="left">0.144</td></tr><tr><td align="left">&#x02003;Chronic kidney disease, n (%)</td><td align="left">2 (0.5)</td><td align="left">1 (0.3)</td><td align="left">1 (1.4)</td><td align="left">0.311</td></tr><tr><td align="left">&#x02003;Chronic liver disease, n (%)</td><td align="left">8 (1.9)</td><td align="left">7 (2.0)</td><td align="left">1 (1.4)</td><td align="left">&#x0003e;&#x02009;0.999</td></tr><tr><td align="left" colspan="5">
<italic>Duration</italic>
</td></tr><tr><td align="left">&#x02003;Onset of illness to admission (days)</td><td align="left">4.67 (2.62)</td><td align="left">4.71 (2.64)</td><td align="left">4.50 (2.52)</td><td align="left">0.544</td></tr><tr><td align="left">&#x02003;Onset of illness to discharge or death (days)</td><td align="left">15.01 (8.99)</td><td align="left">16.06 (9.31)</td><td align="left">9.87 (4.47)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" colspan="5">
<italic>Laboratory finding</italic>
</td></tr><tr><td align="left">&#x02003;WBC count (&#x000d7;10&#x000b3;/&#x000b5;L)</td><td align="left">2.38 (2.01)</td><td align="left">2.36 (1.91)</td><td align="left">2.49 (2.47)</td><td align="left">0.623</td></tr><tr><td align="left">&#x02003;Platelet count (&#x000d7;10&#x000b3;/&#x000b5;L)</td><td align="left">73.86 (39.88)</td><td align="left">76.43 (40.52)</td><td align="left">60.83 (33.81)</td><td align="left">0.004</td></tr><tr><td align="left">&#x02003;Neutrophil count (&#x000d7;10&#x000b3;/&#x000b5;L)</td><td align="left">1.45 (1.52)</td><td align="left">1.42 (1.44)</td><td align="left">1.61 (1.85)</td><td align="left">0.360</td></tr><tr><td align="left">&#x02003;Lymphocyte count (&#x000d7;10&#x000b3;/&#x000b5;L)</td><td align="left">0.70 (0.60)</td><td align="left">0.71 (0.61)</td><td align="left">0.64 (0.58)</td><td align="left">0.404</td></tr><tr><td align="left">&#x02003;Monocyte count (&#x000d7;10&#x000b3;/&#x000b5;L)</td><td align="left">0.16 (0.18)</td><td align="left">0.17 (0.18)</td><td align="left">0.12 (0.14)</td><td align="left">0.038</td></tr><tr><td align="left">&#x02003;Hemoglobin (g/dL)</td><td align="left">13.51 (1.93)</td><td align="left">13.53 (1.94)</td><td align="left">13.46 (1.85)</td><td align="left">0.794</td></tr><tr><td align="left">&#x02003;Hematocrit (%)</td><td align="left">39.89 (5.54)</td><td align="left">39.98 (5.61)</td><td align="left">39.44 (5.20)</td><td align="left">0.463</td></tr><tr><td align="left">&#x02003;Sodium (mmol/L)</td><td align="left">135.42 (4.40)</td><td align="left">135.36 (4.27)</td><td align="left">135.73 (5.02)</td><td align="left">0.528</td></tr><tr><td align="left">&#x02003;Potassium (mmol/L)</td><td align="left">3.94 (0.63)</td><td align="left">3.93 (0.62)</td><td align="left">4.00 (0.66)</td><td align="left">0.414</td></tr><tr><td align="left">&#x02003;AST (IU/L)</td><td align="left">271.12 (373.09)</td><td align="left">213.68 (250.16)</td><td align="left">557.46 (654.14)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;ALT (IU/L)</td><td align="left">107.09 (125.35)</td><td align="left">97.60 (115.39)</td><td align="left">154.14 (158.96)</td><td align="left">0.001</td></tr><tr><td align="left">&#x02003;LDH (IU/L)</td><td align="left">955.63 (1031.54)</td><td align="left">785.73 (637.24)</td><td align="left">1846.88 (1903.13)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Total Bilirubin (mg/dL)</td><td align="left">0.46 (0.38)</td><td align="left">0.44 (0.34)</td><td align="left">0.56 (0.53)</td><td align="left">0.016</td></tr><tr><td align="left">&#x02003;Total Protein (g/dL)</td><td align="left">6.14 (0.72)</td><td align="left">6.21 (0.68)</td><td align="left">5.77 (0.80)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Albumin (g/dL)</td><td align="left">3.58 (0.52)</td><td align="left">3.63 (0.48)</td><td align="left">3.28 (0.59)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;BUN (mg/dL)</td><td align="left">19.60 (13.20)</td><td align="left">19.76 (14.15)</td><td align="left">18.75 (7.08)</td><td align="left">0.845</td></tr><tr><td align="left">&#x02003;Creatinine (mg/dL)</td><td align="left">1.06 (0.63)</td><td align="left">1.03 (0.61)</td><td align="left">1.26 (0.70)</td><td align="left">0.011</td></tr><tr><td align="left">&#x02003;CRP (mg/L)</td><td align="left">5.16 (18.10)</td><td align="left">4.53 (18.49)</td><td align="left">8.70 (15.44)</td><td align="left">0.100</td></tr><tr><td align="left">&#x02003;Troponin I (ng/mL)</td><td align="left">0.77 (4.44)</td><td align="left">0.81 (4.94)</td><td align="left">0.64 (1.37)</td><td align="left">0.860</td></tr><tr><td align="left">&#x02003;CK-MB (ng/mL)</td><td align="left">8.39 (13.27)</td><td align="left">7.32 (12.80)</td><td align="left">12.41 (14.33)</td><td align="left">0.013</td></tr><tr><td align="left">&#x02003;PT (INR)</td><td align="left">1.06 (0.14)</td><td align="left">1.04 (0.09)</td><td align="left">1.16 (0.25)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;aPTT (sec)</td><td align="left">44.46 (14.82)</td><td align="left">42.16 (10.71)</td><td align="left">56.16 (24.41)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;eGFR (mL/min/1.73&#x000a0;m&#x000b2;)</td><td align="left">67.59 (44.13)</td><td align="left">66.84 (43.11)</td><td align="left">71.95 (49.88)</td><td align="left">0.445</td></tr><tr><td align="left" colspan="5">
<italic>Index based on laboratory data</italic>
</td></tr><tr><td align="left">&#x02003;NLR</td><td align="left">2.58 (2.41)</td><td align="left">2.57 (2.52)</td><td align="left">2.65 (1.72)</td><td align="left">0.811</td></tr><tr><td align="left">&#x02003;PLR</td><td align="left">151.99 (106.17)</td><td align="left">154.53 (105.89)</td><td align="left">138.56 (107.52)</td><td align="left">0.274</td></tr><tr><td align="left">&#x02003;MLR</td><td align="left">0.24 (0.18)</td><td align="left">0.25 (0.19)</td><td align="left">0.19 (0.14)</td><td align="left">0.015</td></tr><tr><td align="left">&#x02003;SII</td><td align="left">197.28 (223.55)</td><td align="left">204.72 (237.09)</td><td align="left">157.84 (124.10)</td><td align="left">0.127</td></tr><tr><td align="left">&#x02003;SIRI</td><td align="left">0.44 (0.87)</td><td align="left">0.46 (0.91)</td><td align="left">0.33 (0.63)</td><td align="left">0.257</td></tr><tr><td align="left">&#x02003;AISI</td><td align="left">38.94 (95.88)</td><td align="left">41.85 (101.98)</td><td align="left">23.56 (50.70)</td><td align="left">0.165</td></tr><tr><td align="left">&#x02003;CLR</td><td align="left">9.77 (33.51)</td><td align="left">8.47 (33.30)</td><td align="left">17.15 (34.07)</td><td align="left">0.066</td></tr><tr><td align="left">&#x02003;CAR</td><td align="left">1.58 (5.77)</td><td align="left">1.33 (5.58)</td><td align="left">2.99 (6.63)</td><td align="left">0.040</td></tr><tr><td align="left">&#x02003;BAR</td><td align="left">5.98 (4.37)</td><td align="left">5.90 (4.61)</td><td align="left">6.39 (3.15)</td><td align="left">0.777</td></tr><tr><td align="left">&#x02003;PAR</td><td align="left">20.30 (9.47)</td><td align="left">20.61 (9.47)</td><td align="left">18.70 (9.36)</td><td align="left">0.141</td></tr><tr><td align="left">&#x02003;PNI</td><td align="left">39.29 (5.53)</td><td align="left">39.89 (5.40)</td><td align="left">36.23 (5.19)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;AAR</td><td align="left">2.47 (1.26)</td><td align="left">2.30 (1.10)</td><td align="left">3.35 (1.61)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean (standard deviation) for continuous variables and count (percentage) for categorical variables. Laboratory findings and variable index are evaluated among available data</p><p><italic>Abbreviations</italic> SFTS, Severe fever with thrombocytopenia syndrome; APACHE II Score, Acute Physiology and Chronic Health Evaluation II Score; AST, Aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; BUN, blood urea nitrogen; CRP, C-reactive protein; CK-MB, creatine phosphokinase MB fraction; PT(INR), prothrombin time (International Normalized Ratio); aPTT, activated partial thromboplastin time; eGFR, estimated glomerular filtration rate; NLR, Neutrophil-to-Lymphocyte Ratio; PLR, Platelet-to-Lymphocyte Ratio; MLR, Monocyte-to-Lymphocyte Ratio; SII, Systemic Immune-Inflammation Index; SIRI, Systemic Inflammatory Response Index; AISI, Aggregate Index of Systemic Inflammation; CLR, CRP-to-Lymphocyte Ratio; CAR, CRP-to-Albumin Ratio; BAR, BUN-to-Albumin Ratio; PAR, Platelet-to-Albumin Ratio; PNI, Prognostic Nutritional Index; AAR, AST-to-ALT Ratio</p></table-wrap-foot></table-wrap>
</p><p id="Par36">Laboratory findings at admission also differed between the two groups (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Significant differences in laboratory parameters (platelet count, albumin, AST, ALT, PT[INR], etc.) indicate hepatic dysfunction, coagulopathy, and elevated inflammatory state in non-survivors. In particular, the mean PNI was lower in non-survivors (36.23 vs. 39.89, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001).</p></sec><sec id="Sec8"><title>Independent risk factors for mortality in patients with SFTS</title><p id="Par37">In univariate Cox proportional hazards regression analyses (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>), several variables were associated with an increased hazard of in-hospital mortality. Age, various laboratory biomarkers (e.g., platelet count, AST, ALT, LDH, total bilirubin, total protein, albumin, creatinine, PT(INR), and aPTT) showed statistically significant associations. Among the calculated indices, higher AAR and lower MLR and PNI were each significantly correlated with an increased risk of death (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). LASSO Cox regression analysis identified age, AST, creatinine, PT(INR), aPTT, LDH, PNI, and AAR as candidate predictors, which were subsequently subjected to a multivariate Cox regression model. In the final multivariate Cox regression model, older Age (HR 1.042, 95% CI 1.014&#x02013;1.071, <italic>p</italic>&#x02009;=&#x02009;0.003), elevated PT(INR) (HR 109.565, 95% CI 19.791&#x02013;606.569, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and lower PNI (HR 0.937, 95% CI 0.886&#x02013;0.990, <italic>p</italic>&#x02009;=&#x02009;0.022) remained independently associated with increased mortality risk. Detailed results of the univariate and multivariate Cox regression are shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.</p><p id="Par38">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Risk factors associated with disease prognosis of patients with SFTS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left" colspan="2">Univariate cox regression</th><th align="left" colspan="2">Multivariate cox regression</th></tr><tr><th align="left">Hazards ratio (95% CI)</th><th align="left"><italic>p</italic>-value</th><th align="left">Hazards ratio (95% CI)</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left">Age</td><td char="." align="char">1.040 (1.017, 1.063)</td><td char="." align="char">0.001</td><td char="." align="char">1.042 (1.014, 1.071)</td><td char="." align="char">0.003</td></tr><tr><td align="left">Gender</td><td char="." align="char">1.068 (0.666, 1.712)</td><td char="." align="char">0.786</td><td align="left"/><td align="left"/></tr><tr><td align="left">Height</td><td char="." align="char">1.006 (0.980, 1.032)</td><td char="." align="char">0.645</td><td align="left"/><td align="left"/></tr><tr><td align="left">Weight</td><td char="." align="char">1.008 (0.990, 1.026)</td><td char="." align="char">0.396</td><td align="left"/><td align="left"/></tr><tr><td align="left">WBC count</td><td char="." align="char">1.017 (0.917, 1.127)</td><td char="." align="char">0.749</td><td align="left"/><td align="left"/></tr><tr><td align="left">Neutrophil count</td><td char="." align="char">1.045 (0.918, 1.190)</td><td char="." align="char">0.506</td><td align="left"/><td align="left"/></tr><tr><td align="left">Lymphocyte count</td><td char="." align="char">0.860 (0.534, 1.385)</td><td char="." align="char">0.536</td><td align="left"/><td align="left"/></tr><tr><td align="left">Monocyte count</td><td char="." align="char">0.148 (0.022, 1.010)</td><td char="." align="char">0.051</td><td align="left"/><td align="left"/></tr><tr><td align="left">Hemoglobin</td><td char="." align="char">1.000 (0.889, 1.125)</td><td char="." align="char">0.998</td><td align="left"/><td align="left"/></tr><tr><td align="left">Hematocrit</td><td char="." align="char">0.991 (0.951, 1.032)</td><td char="." align="char">0.656</td><td align="left"/><td align="left"/></tr><tr><td align="left">Platelet count</td><td char="." align="char">0.990 (0.982, 0.998)</td><td char="." align="char">0.018</td><td align="left"/><td align="left"/></tr><tr><td align="left">Sodium</td><td char="." align="char">1.002 (0.969, 1.073)</td><td char="." align="char">0.450</td><td align="left"/><td align="left"/></tr><tr><td align="left">Potassium</td><td char="." align="char">1.144 (0.855, 1.530)</td><td char="." align="char">0.364</td><td align="left"/><td align="left"/></tr><tr><td align="left">AST</td><td char="." align="char">1.001 (1.001, 1.001)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/></tr><tr><td align="left">ALT</td><td char="." align="char">1.002 (1.001, 1.003)</td><td char="." align="char">0.001</td><td align="left"/><td align="left"/></tr><tr><td align="left">LDH</td><td char="." align="char">1.000 (1.000, 1.001)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/></tr><tr><td align="left">Total Bilirubin</td><td char="." align="char">1.550 (1.009, 2.381)</td><td char="." align="char">0.045</td><td align="left"/><td align="left"/></tr><tr><td align="left">Total Protein</td><td char="." align="char">0.512 (0.364, 0.720)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/></tr><tr><td align="left">Albumin</td><td char="." align="char">0.394 (0.257, 0.604)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/></tr><tr><td align="left">BUN</td><td char="." align="char">0.990 (0.927, 1.057)</td><td char="." align="char">0.754</td><td align="left"/><td align="left"/></tr><tr><td align="left">Creatinine</td><td char="." align="char">1.449 (1.073, 1.956)</td><td char="." align="char">0.016</td><td align="left"/><td align="left"/></tr><tr><td align="left">CRP</td><td char="." align="char">1.006 (0.997, 1.014)</td><td char="." align="char">0.176</td><td align="left"/><td align="left"/></tr><tr><td align="left">Troponin I</td><td char="." align="char">0.981 (0.885, 1.087)</td><td char="." align="char">0.710</td><td align="left"/><td align="left"/></tr><tr><td align="left">CK-MB</td><td char="." align="char">1.013 (1.000, 1.027)</td><td char="." align="char">0.056</td><td align="left"/><td align="left"/></tr><tr><td align="left">PT(INR)</td><td char="." align="char">12.304 (5.969, 25.362)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">109.565 (19.791, 606.569)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">aPTT</td><td char="." align="char">1.028 (1.020, 1.037)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/></tr><tr><td align="left">eGFR</td><td char="." align="char">1.002 (0.997, 1.008)</td><td char="." align="char">0.414</td><td align="left"/><td align="left"/></tr><tr><td align="left">NLR</td><td char="." align="char">1.022 (0.916, 1.140)</td><td char="." align="char">0.700</td><td align="left"/><td align="left"/></tr><tr><td align="left">PLR</td><td char="." align="char">0.999 (0.996, 1.001)</td><td char="." align="char">0.332</td><td align="left"/><td align="left"/></tr><tr><td align="left">MLR</td><td char="." align="char">0.109 (0.017, 0.694)</td><td char="." align="char">0.019</td><td align="left"/><td align="left"/></tr><tr><td align="left">SII</td><td char="." align="char">0.999 (0.997, 1.001)</td><td char="." align="char">0.200</td><td align="left"/><td align="left"/></tr><tr><td align="left">SIRI</td><td char="." align="char">0.774 (0.497, 1.207)</td><td char="." align="char">0.258</td><td align="left"/><td align="left"/></tr><tr><td align="left">AISI</td><td char="." align="char">0.996 (0.990, 1.002)</td><td char="." align="char">0.192</td><td align="left"/><td align="left"/></tr><tr><td align="left">CLR</td><td char="." align="char">1.004 (1.000, 1.008)</td><td char="." align="char">0.052</td><td align="left"/><td align="left"/></tr><tr><td align="left">CAR</td><td char="." align="char">1.020 (0.995, 1.045)</td><td char="." align="char">0.114</td><td align="left"/><td align="left"/></tr><tr><td align="left">BAR</td><td char="." align="char">1.018 (0.865, 1.198)</td><td char="." align="char">0.829</td><td align="left"/><td align="left"/></tr><tr><td align="left">PAR</td><td char="." align="char">0.983 (0.955, 1.012)</td><td char="." align="char">0.257</td><td align="left"/><td align="left"/></tr><tr><td align="left">PNI</td><td char="." align="char">0.903 (0.861, 0.948)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">0.937 (0.886, 0.990)</td><td char="." align="char">0.022</td></tr><tr><td align="left">AAR</td><td char="." align="char">1.324 (1.183, 1.481)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic> SFTS, Severe fever with thrombocytopenia syndrome; CI, confidence interval; AST, Aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; BUN, blood urea nitrogen; CRP, C-reactive protein; CK-MB, creatine phosphokinase MB fraction; PT(INR), prothrombin time (International Normalized Ratio); aPTT, activated partial thromboplastin time; eGFR, estimated glomerular filtration rate; NLR, Neutrophil-to-Lymphocyte Ratio; PLR, Platelet-to-Lymphocyte Ratio; MLR, Monocyte-to-Lymphocyte Ratio; SII, Systemic Immune-Inflammation Index; SIRI, Systemic Inflammatory Response Index; AISI, Aggregate Index of Systemic Inflammation; CLR, CRP-to-Lymphocyte Ratio; CAR, CRP-to-Albumin Ratio; BAR, BUN-to-Albumin Ratio; PAR, Platelet-to-Albumin Ratio; PNI, Prognostic Nutritional Index; AAR, AST-to-ALT Ratio</p></table-wrap-foot></table-wrap>
</p><p id="Par39">Stratified Cox regression analyses were performed across subgroups defined by age (&#x0003c;&#x02009;65 vs. &#x02265;65 years), gender (male vs. female), and hospital location (eastern vs. western region of South Korea). PNI was significantly associated with mortality risk in all subgroups except females. (see Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref> for detailed results)</p></sec><sec id="Sec9"><title>Time-dependent ROC analysis and predictive performance</title><p id="Par40">The time-dependent ROC analysis results for age, PT(INR), and PNI are summarized in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. At t&#x02009;=&#x02009;7 days, age showed an AUC of 0.648 with a cut-off of 59, PT(INR) demonstrated an AUC of 0.692 with a cut-off of 1.01, and PNI presented an AUC of 0.716 with a cut-off of 38.78. At t&#x02009;=&#x02009;30 days, age showed an AUC of 0.512 with a cut-off of 59, PT(INR) demonstrated an AUC of 0.857 with a cut-off of 0.97, and PNI presented an AUC of 0.694 with a cut-off of 40.75. Kaplan-Meier survival curves stratified by PNI, PT(INR), and age showed significant survival probability. Patients with low PNI (&#x0003c;&#x02009;40.75), elevated PT(INR) (&#x02265;&#x02009;0.97), or older Age (&#x02265;&#x02009;59 years) had significantly reduced survival probabilities (log-rank test, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 for all comparisons) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). These findings suggest that these predictors may be helpful in identifying patients at high risk of mortality.</p><p id="Par41">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Time-dependent predictive performance of selected variables in multivariable Cox regression for SFTS mortality</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Time (day)</th><th align="left">AUC</th><th align="left">Cut-off value</th><th align="left">Sensitivity</th><th align="left">Specificity</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left">Age</td><td char="." align="char">7</td><td char="." align="char">0.648</td><td align="left">59</td><td char="." align="char">&#x0003e;&#x02009;0.999</td><td char="." align="char">0.279</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Age</td><td char="." align="char">30</td><td char="." align="char">0.512</td><td align="left">59</td><td char="." align="char">0.943</td><td char="." align="char">0.274</td><td char="." align="char">0.545</td></tr><tr><td align="left">PT(INR)</td><td char="." align="char">7</td><td char="." align="char">0.692</td><td align="left">1.01</td><td char="." align="char">0.923</td><td char="." align="char">0.366</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">PT(INR)</td><td char="." align="char">30</td><td char="." align="char">0.857</td><td align="left">0.97</td><td char="." align="char">0.956</td><td char="." align="char">0.593</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">PNI</td><td char="." align="char">7</td><td char="." align="char">0.716</td><td align="left">38.78</td><td char="." align="char">0.856</td><td char="." align="char">0.540</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">PNI</td><td char="." align="char">30</td><td char="." align="char">0.694</td><td align="left">40.75</td><td char="." align="char">0.797</td><td char="." align="char">0.632</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p><italic>Note</italic> The cutoff points were selected by maximizing the sum of sensitivity and specificity</p><p><italic>Abbreviations</italic> SFTS, Severe fever with thrombocytopenia syndrome; AUC, area under the curve; CI, confidence interval; PT(INR), Prothrombin Time International Normalized Ratio; PNI, Prognostic Nutritional Index</p></table-wrap-foot></table-wrap>
</p><p id="Par42">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Kaplan-Meier Survival curves stratified by key prognostic biomarkers in patients with SFTS. <italic>Abbreviations</italic> SFTS, Severe fever with thrombocytopenia syndrome; PT(INR), prothrombin time (International Normalized Ratio); PNI, Prognostic Nutritional Index</p></caption><graphic xlink:href="12879_2025_10661_Fig2_HTML" id="d33e1996"/></fig>
</p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par43">SFTS is a disease that causes a significant public health challenge characterized by high mortality and rapid progression, especially in vulnerable populations such as the elderly and immunocompromised [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Reliable early predictors of disease prognosis are essential to optimizing clinical decision-making and improving patient outcomes. In this study, we defined early prognostic factors as biomarkers or clinical indicators that can be identified at the time of hospital admission or within the first 24&#x000a0;h of admission. Late prognostic factors, on the other hand, are those that become apparent or significant after the initial 24-hour period, often representing the progression of the disease and the patient&#x02019;s response to the initial treatments. Our study, based on a cohort of 413 patients from 9 tertiary referral hospitals in South Korea, found three early predictors, age, PT(INR), and PNI, in providing unique insights into the pathophysiology and clinical progression of SFTS. That is, older age, high PT(INR), and low PNI are independent predictors of mortality in patients with SFTS. Moreover, ROC analysis showed that PT (INR), PNI, and age have good predictive power for in-hospital mortality in patients with SFTS, with PT(INR) being the most predictive.</p><p id="Par44">In this study, indices such as NLR, PLR, MLR, SII, SIRI, AISI, CLR, CAR, BAR, PAR, and AAR, did not show any predictive power for the prognosis of patients with SFTS. This may be due to the specific immunopathogenesis of SFTS, in which other immune and coagulation factors, such as age and PT(INR), are more prominent. MLR and AAR showed some potential for predicting mortality in univariate Cox analyses, but they were not statistically significant in multivariate analyses. Nevertheless, these markers might still be useful in resource-limited settings.</p><p id="Par45">Patients with SFTS often experience hepatic dysfunction, which further worsens inflammation and poor nutritional status [<xref ref-type="bibr" rid="CR42">42</xref>]. The PNI is considered a novel biomarker of the nutritional and immune status [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. It is calculated using serum albumin levels and total lymphocyte counts and provides a comprehensive assessment of a patient&#x02019;s nutritional and immune status. In this study, lower PNI was associated with increased mortality, which indicates the importance of PNI as an independent prognostic biomarker in SFTS. Hypoalbuminemia, a major component of PNI, reflects poor nutrient reserves and systemic inflammation [<xref ref-type="bibr" rid="CR45">45</xref>]. Additionally, lymphopenia, another important component of PNI, suggests that immune competence is impaired, making patients more susceptible to secondary infections and reducing their ability to control their viral load. As a readily available and cost-effective biomarker, PNI can help identify high-risk groups that may benefit from targeted nutrition and immune-boosting interventions. For example, improving albumin levels through diet or supplement support and addressing lymphocyte deficiency with immunomodulatory therapy may mitigate the risks associated with low PNI.</p><p id="Par46">Although our findings demonstrate that low PNI is significantly associated with higher mortality, the current data do not sufficiently support that low PNI alone necessitates early intervention such as close monitoring and more active supportive care. Rather, PNI may improve previously reported prognostic models by considering both nutritional and immune status, thereby assisting in risk classification and potentially informing timely supportive care. However, further prospective studies are needed to determine whether targeted interventions based on low PNI effectively improve mortality.</p><p id="Par47">In this study, age and PT(INR) were also found to be significant predictors of mortality. Consistent with previous studies, older age is associated with worse outcomes in infectious diseases, mainly due to immunosenescence and comorbidities [<xref ref-type="bibr" rid="CR46">46</xref>]. Prolonged PT(INR) indicates coagulopathy and liver dysfunction, which play an important role in the pathophysiology of SFTS [<xref ref-type="bibr" rid="CR47">47</xref>]. Unlike other biomarkers that may focus on a single pathophysiological mechanism, PNI represents multiple physiological domains (nutritional status and immune competence), offering a more comprehensive perspective compared to other established predictors such as age and PT(INR).</p><sec id="Sec11"><title>Limitations</title><p id="Par48">Due to the retrospective design of the study, it may cause biases related to data collection and interpretation. First, missing data was inevitable, and our use of the pairwise deletion method to handle it may have led to the potential for selection bias. Second, the study did not include viral load measurements, which could have provided additional information on disease progression and prognostic implications, because viral load measurements are not conducted in routine clinical practice. Third, since only in-hospital mortality was recorded, any deaths occurring after discharge were not collected, potentially underestimating the overall mortality associated with SFTS. The limitation of using LASSO regression for variable selection is that the shrinkage penalty may exclude predictors with borderline significance, especially when multicollinearity is present. Although 10-fold cross-validation was used to select the optimal lambda (&#x003bb;), this approach may bias effect size estimates.</p></sec></sec><sec id="Sec12"><title>Conclusions</title><p id="Par49">In this nationwide multicenter study of 413 patients with SFTS, we identified older age, elevated PT(INR), and low PNI as early predictors of in-hospital mortality in SFTS patients. In particular, PNI is a novel early predictor that has not been previously studied. Our findings suggest that enhanced prognostic models with PNI may improve the precision of mortality prediction. However, the relatively small sample size may constrain the robustness of the identified predictors. Therefore, further studies with larger, prospectively designed, multicenter cohorts are needed to validate these results.</p></sec><sec id="Sec13" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12879_2025_10661_MOESM1_ESM.docx"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>HJW, TKK, JHH, and MGK conceived and designed the study. STH, JRY, MK, JO, IGB, SB, YRY, MH, HAK, SIJ, KTK, SH, UJK, GK, YJK, JHH, HJW, and MGK collected and organized the data. HJW and MGK analyzed the data, prepared the figures and tables, and wrote the manuscript. All authors reviewed and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by a grant from the Korea Health Technology R&#x00026;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &#x00026; Welfare, Republic of Korea (Grant number: HI22C0797).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated and/or analysed during the current study are not publicly available due to secrecy.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par50">The study was approved by the institutional review board of Chonnam National University Hospital (IRB# CNUH-2023-213), Chonnam National University Hwasun Hospital (IRB# CNUH-2024-150), Gyeongsang National University Hospital (IRB# GNUH 2024-08-020), Jeju National University Hospital (IRB# JEJUNUH 2024-08-002), Jeonbuk National University Hospital (IRB# CUH 2022-01-067), Keimyung University Dongsan Hospital (IRB# DSMC 2024-08-008), Kyungpook National University Chilgok Hospital (IRB# DGIRB 2022-05-004), Kyungpook National University Hospital (IRB# DGIRB 2023-07-001), Wonkwang University Hospital (IRB# WKUH 2024-08-005). The data were kept confidential; no one except the research team had access to the files.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par51">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par52">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>XJ</given-names></name><name><surname>Liang</surname><given-names>MF</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>JD</given-names></name><name><surname>Sun</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>QF</given-names></name><name><surname>Popov</surname><given-names>VL</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group><article-title>Fever with thrombocytopenia associated with a novel bunyavirus in China</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><issue>16</issue><fpage>1523</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1010095</pub-id><pub-id pub-id-type="pmid">21410387</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523&#x02013;32.<pub-id pub-id-type="pmid">21410387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Jun</surname><given-names>KI</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Choe</surname><given-names>PG</given-names></name><name><surname>Kim</surname><given-names>NJ</given-names></name><name><surname>Lee</surname><given-names>JK</given-names></name><name><surname>Oh</surname><given-names>MD</given-names></name></person-group><article-title>Severe fever with thrombocytopenia syndrome, South Korea, 2012</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><issue>11</issue><fpage>1892</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.3201/eid1911.130792</pub-id><pub-id pub-id-type="pmid">24206586</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Kim KH, Yi J, Kim G, Choi SJ, Jun KI, Kim NH, Choe PG, Kim NJ, Lee JK, Oh MD. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis. 2013;19(11):1892&#x02013;4.<pub-id pub-id-type="pmid">24206586</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Ishido</surname><given-names>A</given-names></name><name><surname>Shigeoka</surname><given-names>T</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name><name><surname>Kamei</surname><given-names>T</given-names></name><name><surname>Honda</surname><given-names>M</given-names></name><name><surname>Ninomiya</surname><given-names>D</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><etal/></person-group><article-title>The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan</article-title><source>J Infect Dis</source><year>2014</year><volume>209</volume><issue>6</issue><fpage>816</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit603</pub-id><pub-id pub-id-type="pmid">24231186</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, Kamei T, Honda M, Ninomiya D, Sakai T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis. 2014;209(6):816&#x02013;27.<pub-id pub-id-type="pmid">24231186</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>XC</given-names></name><name><surname>Yun</surname><given-names>Y</given-names></name><name><surname>Van An</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Thao</surname><given-names>NTP</given-names></name><name><surname>Man</surname><given-names>PKC</given-names></name><name><surname>Yoo</surname><given-names>JR</given-names></name><name><surname>Heo</surname><given-names>ST</given-names></name><name><surname>Cho</surname><given-names>NH</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name></person-group><article-title>Endemic severe fever with thrombocytopenia syndrome, Vietnam</article-title><source>Emerg Infect Dis</source><year>2019</year><volume>25</volume><issue>5</issue><fpage>1029</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.3201/eid2505.181463</pub-id><pub-id pub-id-type="pmid">31002059</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Tran XC, Yun Y, Van An L, Kim SH, Thao NTP, Man PKC, Yoo JR, Heo ST, Cho NH, Lee KH. Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg Infect Dis. 2019;25(5):1029&#x02013;31.<pub-id pub-id-type="pmid">31002059</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name></person-group><article-title>Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus</article-title><source>Crit Rev Microbiol</source><year>2021</year><volume>47</volume><issue>1</issue><fpage>112</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2020.1847037</pub-id><pub-id pub-id-type="pmid">33245676</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Li J, Li S, Yang L, Cao P, Lu J. Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus. Crit Rev Microbiol. 2021;47(1):112&#x02013;25.<pub-id pub-id-type="pmid">33245676</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Yong</surname><given-names>L</given-names></name><name><surname>Chao</surname><given-names>W</given-names></name></person-group><article-title>Occupational severe fever with thrombocytopenia syndrome following Needle-Stick injury</article-title><source>Infect Control Hosp Epidemiol</source><year>2017</year><volume>38</volume><issue>6</issue><fpage>760</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1017/ice.2017.61</pub-id><pub-id pub-id-type="pmid">28397631</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Chen Y, Jia B, Huang R, Yan X, Xiong Y, Yong L, Chao W. Occupational severe fever with thrombocytopenia syndrome following Needle-Stick injury. Infect Control Hosp Epidemiol. 2017;38(6):760&#x02013;2.<pub-id pub-id-type="pmid">28397631</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Heo</surname><given-names>ST</given-names></name></person-group><article-title>Surveillance results for family members of patients with severe fever with thrombocytopenia syndrome</article-title><source>Zoonoses Public Health</source><year>2018</year><volume>65</volume><issue>8</issue><fpage>903</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/zph.12481</pub-id><pub-id pub-id-type="pmid">29862661</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Yoo JR, Lee KH, Heo ST. Surveillance results for family members of patients with severe fever with thrombocytopenia syndrome. Zoonoses Public Health. 2018;65(8):903&#x02013;7.<pub-id pub-id-type="pmid">29862661</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Bai</surname><given-names>H</given-names></name><name><surname>Abdullah</surname><given-names>AS</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name></person-group><article-title>Two confirmed cases of severe fever with thrombocytopenia syndrome with pneumonia: implication for a family cluster in East China</article-title><source>BMC Infect Dis</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>537</fpage><pub-id pub-id-type="doi">10.1186/s12879-017-2645-9</pub-id><pub-id pub-id-type="pmid">28774267</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Zhu Y, Wu H, Gao J, Zhou X, Zhu R, Zhang C, Bai H, Abdullah AS, Pan H. Two confirmed cases of severe fever with thrombocytopenia syndrome with pneumonia: implication for a family cluster in East China. BMC Infect Dis. 2017;17(1):537.<pub-id pub-id-type="pmid">28774267</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Mehand MS, Millett P, Al-Shorbaji F, Roth C, Kieny MP, Murgue B. World Health Organization methodology to prioritize emerging infectious diseases in need of research and development. Emerg Infect Dis. 2018;24(9).</mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Brault AC, Savage HM, Duggal NK, Eisen RJ, Staples JE. Heartland virus epidemiology, vector association, and disease potential. Viruses. 2018;10(9).</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Li XK, Lu QB, Chen WW, Xu W, Liu R, Zhang SF, Du J, Li H, Yao K, Zhai D et al. Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci Transl Med. 2018;10(459).</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>YI</given-names></name><name><surname>Park</surname><given-names>A</given-names></name><name><surname>Kwon</surname><given-names>HI</given-names></name><name><surname>Kim</surname><given-names>EH</given-names></name><name><surname>Si</surname><given-names>YJ</given-names></name><name><surname>Song</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Jung</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis</article-title><source>Nat Microbiol</source><year>2019</year><volume>4</volume><issue>3</issue><fpage>438</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0317-1</pub-id><pub-id pub-id-type="pmid">30531978</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Park SJ, Kim YI, Park A, Kwon HI, Kim EH, Si YJ, Song MS, Lee CH, Jung K, Shin WJ, et al. Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis. Nat Microbiol. 2019;4(3):438&#x02013;46.<pub-id pub-id-type="pmid">30531978</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Niyonsaba</surname><given-names>A</given-names></name><name><surname>Tong</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Jie</surname><given-names>S</given-names></name></person-group><article-title>Detection and evaluation of Immunofunction of patients with severe fever with thrombocytopenia syndrome</article-title><source>Clin Exp Med</source><year>2014</year><volume>14</volume><issue>4</issue><fpage>389</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1007/s10238-013-0259-0</pub-id><pub-id pub-id-type="pmid">24068614</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Sun L, Hu Y, Niyonsaba A, Tong Q, Lu L, Li H, Jie S. Detection and evaluation of Immunofunction of patients with severe fever with thrombocytopenia syndrome. Clin Exp Med. 2014;14(4):389&#x02013;95.<pub-id pub-id-type="pmid">24068614</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Yi</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome</article-title><source>J Med Virol</source><year>2021</year><volume>93</volume><issue>8</issue><fpage>4704</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/jmv.26877</pub-id><pub-id pub-id-type="pmid">33590892</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">He Z, Wang B, Li Y, Hu K, Yi Z, Ma H, Li X, Guo W, Xu B, Huang X. Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome. J Med Virol. 2021;93(8):4704&#x02013;13.<pub-id pub-id-type="pmid">33590892</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JW</given-names></name><name><surname>Chu</surname><given-names>M</given-names></name><name><surname>Jiao</surname><given-names>YJ</given-names></name><name><surname>Zhou</surname><given-names>CM</given-names></name><name><surname>Qi</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>XJ</given-names></name></person-group><article-title>SFTSV infection induced Interleukin-1beta secretion through NLRP3 inflammasome activation</article-title><source>Front Immunol</source><year>2021</year><volume>12</volume><fpage>595140</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2021.595140</pub-id><pub-id pub-id-type="pmid">33708197</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Liu JW, Chu M, Jiao YJ, Zhou CM, Qi R, Yu XJ. SFTSV infection induced Interleukin-1beta secretion through NLRP3 inflammasome activation. Front Immunol. 2021;12:595140.<pub-id pub-id-type="pmid">33708197</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>YH</given-names></name><name><surname>Yang</surname><given-names>ZQ</given-names></name></person-group><article-title>The cytokine storm of severe influenza and development of Immunomodulatory therapy</article-title><source>Cell Mol Immunol</source><year>2016</year><volume>13</volume><issue>1</issue><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/cmi.2015.74</pub-id><pub-id pub-id-type="pmid">26189369</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of Immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3&#x02013;10.<pub-id pub-id-type="pmid">26189369</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Lyu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><etal/></person-group><article-title>Clinical progress and risk factors for death from severe fever with thrombocytopenia syndrome: A multihospital retrospective investigation in Anhui, China</article-title><source>Am J Trop Med Hyg</source><year>2021</year><volume>104</volume><issue>4</issue><fpage>1425</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.20-0270</pub-id><pub-id pub-id-type="pmid">33591933</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gong L, Zhang L, Wu J, Lu S, Lyu Y, Zhu M, Liu B, Zhu Y, Song D, Su B, et al. Clinical progress and risk factors for death from severe fever with thrombocytopenia syndrome: A multihospital retrospective investigation in Anhui, China. Am J Trop Med Hyg. 2021;104(4):1425&#x02013;31.<pub-id pub-id-type="pmid">33591933</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Mu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name></person-group><article-title>Analysis of clinical features and early warning indicators of death from severe fever with thrombocytopenia syndrome</article-title><source>Int J Infect Dis</source><year>2018</year><volume>73</volume><fpage>43</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2018.05.013</pub-id><pub-id pub-id-type="pmid">29859247</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Xu X, Sun Z, Liu J, Zhang J, Liu T, Mu X, Jiang M. Analysis of clinical features and early warning indicators of death from severe fever with thrombocytopenia syndrome. Int J Infect Dis. 2018;73:43&#x02013;8.<pub-id pub-id-type="pmid">29859247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>The prognostic significance of C-Reactive protein to albumin ratio in patients with severe fever with thrombocytopenia syndrome</article-title><source>Front Med (Lausanne)</source><year>2022</year><volume>9</volume><fpage>879982</fpage><pub-id pub-id-type="doi">10.3389/fmed.2022.879982</pub-id><pub-id pub-id-type="pmid">35572999</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Yang X, Yin H, Xiao C, Li R, Liu Y. The prognostic significance of C-Reactive protein to albumin ratio in patients with severe fever with thrombocytopenia syndrome. Front Med (Lausanne). 2022;9:879982.<pub-id pub-id-type="pmid">35572999</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Paliogiannis</surname><given-names>P</given-names></name><name><surname>Satta</surname><given-names>R</given-names></name><name><surname>Deligia</surname><given-names>G</given-names></name><name><surname>Farina</surname><given-names>G</given-names></name><name><surname>Bassu</surname><given-names>S</given-names></name><name><surname>Mangoni</surname><given-names>AA</given-names></name><name><surname>Carru</surname><given-names>C</given-names></name><name><surname>Zinellu</surname><given-names>A</given-names></name></person-group><article-title>Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis</article-title><source>Clin Exp Med</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s10238-018-0538-x</pub-id><pub-id pub-id-type="pmid">30478648</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Paliogiannis P, Satta R, Deligia G, Farina G, Bassu S, Mangoni AA, Carru C, Zinellu A. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med. 2019;19(1):37&#x02013;45.<pub-id pub-id-type="pmid">30478648</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>Z</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>D</given-names></name><etal/></person-group><article-title>The predictive effect of the platelet-to-lymphocyte ratio (PLR) and the neutrophil-to-lymphocyte ratio (NLR) on the risk of death in patients with severe fever with thrombocytopenia syndrome (SFTS): a multi-center study in China</article-title><source>Ann Transl Med</source><year>2021</year><volume>9</volume><issue>3</issue><fpage>208</fpage><pub-id pub-id-type="doi">10.21037/atm-20-4736</pub-id><pub-id pub-id-type="pmid">33708835</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Wang X, Lin L, Zhao Z, Zhou W, Ge Z, Shen Y, Wang L, Zhang W, Song R, Tian D, et al. The predictive effect of the platelet-to-lymphocyte ratio (PLR) and the neutrophil-to-lymphocyte ratio (NLR) on the risk of death in patients with severe fever with thrombocytopenia syndrome (SFTS): a multi-center study in China. Ann Transl Med. 2021;9(3):208.<pub-id pub-id-type="pmid">33708835</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>Z</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>High C-reactive protein to lymphocyte ratio predicts mortality outcomes of patients with severe fever with thrombocytopenia syndrome: A multicenter study in China</article-title><source>J Med Virol</source><year>2023</year><volume>95</volume><issue>2</issue><fpage>e28546</fpage><pub-id pub-id-type="doi">10.1002/jmv.28546</pub-id><pub-id pub-id-type="pmid">36734063</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Qian F, Zhou W, Liu Y, Ge Z, Lai J, Zhao Z, Feng Y, Lin L, Shen Y, Zhang Z, et al. High C-reactive protein to lymphocyte ratio predicts mortality outcomes of patients with severe fever with thrombocytopenia syndrome: A multicenter study in China. J Med Virol. 2023;95(2):e28546.<pub-id pub-id-type="pmid">36734063</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Ge</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>A</given-names></name><etal/></person-group><article-title>High levels of C-reactive protein-to-albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage</article-title><source>J Med Virol</source><year>2022</year><volume>94</volume><issue>11</issue><fpage>5375</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1002/jmv.27972</pub-id><pub-id pub-id-type="pmid">35790466</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Liu Z, Zhang R, Zhou W, Ma R, Han L, Zhao Z, Ge Z, Ren X, Zhang W, Sun A, et al. High levels of C-reactive protein-to-albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage. J Med Virol. 2022;94(11):5375&#x02013;84.<pub-id pub-id-type="pmid">35790466</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name></person-group><article-title>Blood Urea Nitrogen-to-Serum albumin ratio predicts fatal outcomes in severe fever with thrombocytopenia syndrome patients</article-title><source>Am J Trop Med Hyg</source><year>2024</year><volume>111</volume><issue>1</issue><fpage>113</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.23-0811</pub-id><pub-id pub-id-type="pmid">38806039</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Cao K, Ma A, Zhang K, Zhang Y, Xiang X, Xu C, Han B, Xu Y, Tang L. Blood Urea Nitrogen-to-Serum albumin ratio predicts fatal outcomes in severe fever with thrombocytopenia syndrome patients. Am J Trop Med Hyg. 2024;111(1):113&#x02013;20.<pub-id pub-id-type="pmid">38806039</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>LH</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>DW</given-names></name><name><surname>Wang</surname><given-names>WJ</given-names></name><name><surname>Xu</surname><given-names>AM</given-names></name><name><surname>Qi</surname><given-names>YJ</given-names></name></person-group><article-title>Blood Urea nitrogen to albumin ratio is a novel predictor of fatal outcome for patients with severe fever with thrombocytopenia syndrome</article-title><source>J Med Virol</source><year>2024</year><volume>96</volume><issue>6</issue><fpage>e29731</fpage><pub-id pub-id-type="doi">10.1002/jmv.29731</pub-id><pub-id pub-id-type="pmid">38888065</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Wang Y, Qin LH, Zhang K, Zhang DW, Wang WJ, Xu AM, Qi YJ. Blood Urea nitrogen to albumin ratio is a novel predictor of fatal outcome for patients with severe fever with thrombocytopenia syndrome. J Med Virol. 2024;96(6):e29731.<pub-id pub-id-type="pmid">38888065</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Bibi</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><article-title>The AST/ALT ratio (De Ritis ratio) represents an unfavorable prognosis in patients in Early-Stage SFTS: an observational cohort study</article-title><source>Front Cell Infect Microbiol</source><year>2022</year><volume>12</volume><fpage>725642</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.725642</pub-id><pub-id pub-id-type="pmid">35211422</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Wang L, Xu Y, Zhang S, Bibi A, Xu Y, Li T. The AST/ALT ratio (De Ritis ratio) represents an unfavorable prognosis in patients in Early-Stage SFTS: an observational cohort study. Front Cell Infect Microbiol. 2022;12:725642.<pub-id pub-id-type="pmid">35211422</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>KW</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name><name><surname>Jeong</surname><given-names>HY</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>H</given-names></name></person-group><article-title>Systemic immune-inflammation index is associated with white matter hyperintensity volume</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>7379</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-11575-0</pub-id><pub-id pub-id-type="pmid">35513435</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H. Systemic immune-inflammation index is associated with white matter hyperintensity volume. Sci Rep. 2022;12(1):7379.<pub-id pub-id-type="pmid">35513435</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of All-Cause mortality and cardiovascular mortality: A 20-Year Follow-Up cohort study of 42,875 US adults. J Clin Med. 2023;12(3).</mixed-citation></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Bao</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension</article-title><source>Front Cardiovasc Med</source><year>2023</year><volume>10</volume><fpage>1163900</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2023.1163900</pub-id><pub-id pub-id-type="pmid">37265570</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Xiu J, Lin X, Chen Q, Yu P, Lu J, Yang Y, Chen W, Bao K, Wang J, Zhu J, et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front Cardiovasc Med. 2023;10:1163900.<pub-id pub-id-type="pmid">37265570</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Onodera</surname><given-names>T</given-names></name><name><surname>Goseki</surname><given-names>N</given-names></name><name><surname>Kosaki</surname><given-names>G</given-names></name></person-group><article-title>[Prognostic nutritional index in Gastrointestinal surgery of malnourished cancer patients]</article-title><source>Nihon Geka Gakkai Zasshi</source><year>1984</year><volume>85</volume><issue>9</issue><fpage>1001</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">6438478</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in Gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001&#x02013;5.<pub-id pub-id-type="pmid">6438478</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Ao</surname><given-names>S</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>F</given-names></name><name><surname>Tian</surname><given-names>N</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Platelet-to-albumin ratio: a potential biomarker for predicting all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis</article-title><source>BMC Nephrol</source><year>2024</year><volume>25</volume><issue>1</issue><fpage>365</fpage><pub-id pub-id-type="doi">10.1186/s12882-024-03792-8</pub-id><pub-id pub-id-type="pmid">39427118</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Ma H, Chen J, Zhan X, Ao S, Deng J, Tang R, Peng F, Tian N, Wen Y, Wang X, et al. Platelet-to-albumin ratio: a potential biomarker for predicting all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis. BMC Nephrol. 2024;25(1):365.<pub-id pub-id-type="pmid">39427118</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Cheng YL, Sung SH, Cheng HM, Hsu PF, Guo CY, Yu WC, Chen CH. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J Am Heart Assoc. 2017;6(6).</mixed-citation></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Xiang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><etal/></person-group><article-title>Liver function derangement in patients with severe fever and thrombocytopenia syndrome</article-title><source>J Clin Transl Hepatol</source><year>2022</year><volume>10</volume><issue>5</issue><fpage>825</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.14218/JCTH.2021.00345</pub-id><pub-id pub-id-type="pmid">36304508</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Lu S, Xu L, Liang B, Wang H, Wang T, Xiang T, Li S, Fan L, Li J, Peng C, et al. Liver function derangement in patients with severe fever and thrombocytopenia syndrome. J Clin Transl Hepatol. 2022;10(5):825&#x02013;34.<pub-id pub-id-type="pmid">36304508</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Yang T, Huang H, Jiang L, Li J. Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review). Int J Mol Med. 2022;50(3).</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a meta-analysis and systemic review</article-title><source>Front Nutr</source><year>2024</year><volume>11</volume><fpage>1433528</fpage><pub-id pub-id-type="doi">10.3389/fnut.2024.1433528</pub-id><pub-id pub-id-type="pmid">39764415</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Zhang H, Li D, Li J. Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a meta-analysis and systemic review. Front Nutr. 2024;11:1433528.<pub-id pub-id-type="pmid">39764415</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name></person-group><article-title>Predictive value of prognostic nutritional index in patients undergoing gastrectomy for gastric cancer: A systematic review and meta-analysis</article-title><source>Med (Baltim)</source><year>2024</year><volume>103</volume><issue>41</issue><fpage>e39917</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000039917</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Deng H, He Y, Huang G, Huang Y, Wu J, Qin X. Predictive value of prognostic nutritional index in patients undergoing gastrectomy for gastric cancer: A systematic review and meta-analysis. Med (Baltim). 2024;103(41):e39917.</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Tobing</surname><given-names>E</given-names></name><name><surname>Tansol</surname><given-names>C</given-names></name><name><surname>Tania</surname><given-names>C</given-names></name><name><surname>Sihombing</surname><given-names>AT</given-names></name></person-group><article-title>Prognostic nutritional index (PNI) as independent predictor of poor survival in prostate cancer: A systematic review and Meta-Analysis</article-title><source>Clin Genitourin Cancer</source><year>2024</year><volume>22</volume><issue>5</issue><fpage>102142</fpage><pub-id pub-id-type="doi">10.1016/j.clgc.2024.102142</pub-id><pub-id pub-id-type="pmid">39079465</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Tobing E, Tansol C, Tania C, Sihombing AT. Prognostic nutritional index (PNI) as independent predictor of poor survival in prostate cancer: A systematic review and Meta-Analysis. Clin Genitourin Cancer. 2024;22(5):102142.<pub-id pub-id-type="pmid">39079465</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name></person-group><article-title>Values of prognostic nutritional index for predicting Kawasaki disease: a systematic review and meta-analysis</article-title><source>Front Nutr</source><year>2024</year><volume>11</volume><fpage>1305775</fpage><pub-id pub-id-type="doi">10.3389/fnut.2024.1305775</pub-id><pub-id pub-id-type="pmid">38371499</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Zhong X, Xie Y, Wang H, Chen G, Yang T, Xie J. Values of prognostic nutritional index for predicting Kawasaki disease: a systematic review and meta-analysis. Front Nutr. 2024;11:1305775.<pub-id pub-id-type="pmid">38371499</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>HW</given-names></name></person-group><article-title>Pairwise deletion for missing data in structural equation models: nonpositive definite matrices, parameter estimates, goodness of fit, and adjusted sample sizes</article-title><source>Struct Equ Model</source><year>1998</year><volume>5</volume><fpage>22</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1080/10705519809540087</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Marsh HW. Pairwise deletion for missing data in structural equation models: nonpositive definite matrices, parameter estimates, goodness of fit, and adjusted sample sizes. Struct Equ Model. 1998;5:22&#x02013;36.</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>TL</given-names></name><name><surname>Ou</surname><given-names>SC</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Shimoda</surname><given-names>H</given-names></name><name><surname>Chan</surname><given-names>JP</given-names></name><name><surname>Tu</surname><given-names>WC</given-names></name><name><surname>Hsu</surname><given-names>WL</given-names></name><name><surname>Chou</surname><given-names>CC</given-names></name></person-group><article-title>The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan</article-title><source>Emerg Microbes Infect</source><year>2020</year><volume>9</volume><issue>1</issue><fpage>148</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1080/22221751.2019.1710436</pub-id><pub-id pub-id-type="pmid">31918622</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Lin TL, Ou SC, Maeda K, Shimoda H, Chan JP, Tu WC, Hsu WL, Chou CC. The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan. Emerg Microbes Infect. 2020;9(1):148&#x02013;51.<pub-id pub-id-type="pmid">31918622</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>SY</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>XQ</given-names></name></person-group><article-title>Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><issue>8</issue><fpage>763</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(14)70718-2</pub-id><pub-id pub-id-type="pmid">24837566</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Liu Q, He B, Huang SY, Wei F, Zhu XQ. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis. 2014;14(8):763&#x02013;72.<pub-id pub-id-type="pmid">24837566</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>G</given-names></name><name><surname>Gan</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Hua</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>N</given-names></name><name><surname>Xiang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19</article-title><source>Int Immunopharmacol</source><year>2020</year><volume>89</volume><issue>Pt A</issue><fpage>107065</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2020.107065</pub-id><pub-id pub-id-type="pmid">33045571</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Xue G, Gan X, Wu Z, Xie D, Xiong Y, Hua L, Zhou B, Zhou N, Xiang J, Li J. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19. Int Immunopharmacol. 2020;89(Pt A):107065.<pub-id pub-id-type="pmid">33045571</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Salati</surname><given-names>M</given-names></name><name><surname>Filippi</surname><given-names>R</given-names></name><name><surname>Vivaldi</surname><given-names>C</given-names></name><name><surname>Caputo</surname><given-names>F</given-names></name><name><surname>Leone</surname><given-names>F</given-names></name><name><surname>Salani</surname><given-names>F</given-names></name><name><surname>Cerma</surname><given-names>K</given-names></name><name><surname>Aglietta</surname><given-names>M</given-names></name><name><surname>Fornaro</surname><given-names>L</given-names></name><name><surname>Sperti</surname><given-names>E</given-names></name><etal/></person-group><article-title>The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer</article-title><source>Liver Int</source><year>2020</year><volume>40</volume><issue>3</issue><fpage>704</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1111/liv.14314</pub-id><pub-id pub-id-type="pmid">31773848</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Salati M, Filippi R, Vivaldi C, Caputo F, Leone F, Salani F, Cerma K, Aglietta M, Fornaro L, Sperti E, et al. The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. Liver Int. 2020;40(3):704&#x02013;11.<pub-id pub-id-type="pmid">31773848</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>Y</given-names></name></person-group><article-title>The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis</article-title><source>J Cancer Res Clin Oncol</source><year>2014</year><volume>140</volume><issue>9</issue><fpage>1537</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1007/s00432-014-1714-3</pub-id><pub-id pub-id-type="pmid">24878931</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Sun K, Chen S, Xu J, Li G, He Y. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2014;140(9):1537&#x02013;49.<pub-id pub-id-type="pmid">24878931</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanghera</surname><given-names>C</given-names></name><name><surname>Teh</surname><given-names>JJ</given-names></name><name><surname>Pinato</surname><given-names>DJ</given-names></name></person-group><article-title>The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma</article-title><source>Liver Int</source><year>2019</year><volume>39</volume><issue>11</issue><fpage>2008</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1111/liv.14220</pub-id><pub-id pub-id-type="pmid">31433891</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Sanghera C, Teh JJ, Pinato DJ. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma. Liver Int. 2019;39(11):2008&#x02013;23.<pub-id pub-id-type="pmid">31433891</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Niu</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Age is a critical risk factor for severe fever with thrombocytopenia syndrome</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>11</issue><fpage>e111736</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0111736</pub-id><pub-id pub-id-type="pmid">25369237</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Ding S, Niu G, Xu X, Li J, Zhang X, Yin H, Zhang N, Jiang X, Wang S, Liang M, et al. Age is a critical risk factor for severe fever with thrombocytopenia syndrome. PLoS ONE. 2014;9(11):e111736.<pub-id pub-id-type="pmid">25369237</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Clinical value of coagulation parameters in predicting the severity of severe fever with thrombocytopenia syndrome</article-title><source>Front Microbiol</source><year>2024</year><volume>15</volume><fpage>1335664</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2024.1335664</pub-id><pub-id pub-id-type="pmid">38633697</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Xia Y, Jia B, Chen Y, Wang S, Xu X. Clinical value of coagulation parameters in predicting the severity of severe fever with thrombocytopenia syndrome. Front Microbiol. 2024;15:1335664.<pub-id pub-id-type="pmid">38633697</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>